Neutralization of different geographic strains of the hepatitis E virus with anti-hepatitis E virus-positive serum samples obtained from different sources

Virology

Volumn 249, Issue 2, 1998, Pages 316-324

  Meng, Jihong ^a,b   Pillot, Jacques ^c   Dai, Xing ^a,d   Fields, Howard A ^a   Khudyakov, Yury E ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

^c INSTITUT PASTEUR   (France)

^d PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; HEPATITIS VIRUS; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; VIRUS NEUTRALIZATION; VIRUS STRAIN;

EID: 0032582051     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9346     Document Type: Article

References (58)

1. Arankalle V. A., Chadha M. S., Chobe L. P., Nair R., Banerjee K. Cross-challenge studies in rhesus monkeys employing different Indian isolates of hepatitis E virus. J. Med. Virol. 46:1995;358-363.
2. Arankalle V. A., Favorov M. O., Chadha M. S., Phule D. M., Banerjee K. Rhesus monkeys infected with hepatitis E virus (HEV) from the former USSR are immune to subsequent challenge with an Indian strain of HEV. Acta Virol. 37:1993;515-518.
3. Aye T. T., Uchida T., Ma X., Iida F., Shikata T., Ichikawa M., Rikihisa T., Win K. M. Sequence and gene structure of the hepatitis E virus isolated from Myanmar. Virus Genes. 7:1993;95-110.
4. Aye T. T., Uchida T., Ma X.-Z., Iida F., Shikata T., Zhuang H., Win K. M. Complete nucleotide sequence of a hepatitis E virus isolated from the Xinjiang epidemic (1986-1988) of China. Nucleic Acids Res. 20:1992a;3512-3512.
5. Aye T. T., Uchida T., Ma X., Iida F., Shikata T., Zhuang H., Win K. M. Sequence comparison of the capsid region of hepatitis E virus isolated from Myanmar and China. Microbiol. Immunol. 36:1992b;615-621.
6. Balayan M. S., Andjaparidze A. G., Savinskaya S. S., Ketiladze E. S., Braginsky D. M., Savinoz A. P., Poleschuk V. F. Evidence for a virus in non-A, non-B hepatitis transmitted via the fecal oral route. Intervirology. 20:1983;23-31.
7. Benjelloun S., Bahbouhi B., Bouchrit N., Cherkaoui L., Hda N., Mahjour J., Benslimane A. Seroepidemiological study of an acute hepatitis E outbreak in Morocco. Res. Virol. 148:1997;279-287.
8. Bi S.-L., Purdy M. A., McCaustland K. A., Margolis H. S., Bradley D. W. The sequence of hepatitis E virus isolated directly from a single source during an outbreak in China. Virus Res. 28:1993;233-247.
9. Bradley D. W. Enterically-transmitted non-A, non-B hepatitis. Br. Med. Bull. 46:1990;442-461.
10. Bradley D. W., Andjaparidze A., Cook E. H. Jr., McCaustland K., Balayan M., Stetler H., Velazquez O., Robertson B., Humphrey C., Kane M., Weisfuse I. Aetiological agent of enterically transmitted non-A, non-B hepatitis. J. Gen. Virol. 69:1988;731-738.
11. Bradley D. W., Krawczynski K., Cook E. H. Jr., McCaustland K. A., Humphrey C. D., Spelbring J. E., Myint H., Maynard J. E. Enterically transmitted non-A, non-B hepatitis: Serial passage of disease in cynomolgus macaques and tamarins and recovery of disease-associated 27-34 nm virus-like particles. Proc. Natl. Acad. Sci. USA. 84:1987;6277-6281.
12. MMWR. 42:1993;1-4.
13. Chatterjee R., Tsarev S., Pillot J., Coursaget P., Emerson S. U., Purcell R. H. African strains of hepatitis E virus that are distinct from Asian strains. J. Med. Virol. 53:1997;139-144.
14. Coursaget, P. Buisson, Y. Enogat, N. Nahor, M. Gawara, N. Roué, R. Molinié, C. Desrame, J. Bercion, R. Touzé, A. Gharbi, Y. Kastally, R. 1996, Hepatitis E virus infections in France and Africa, In, Enterically-Transmitted Hepatitis Viruses, 201, 212, La Simarre, Joué-lès-Tours, France.
15. Datta R., Panda S. K., Tandon B. N., Madnagopalan N., Bose S. L., Acharya S. K., Nayak N. C. Acute sporadic non-A, non-B viral hepatitis of adults in India: Epidemiological and imuunological studies. J. Gastroenterol. Hepatol. 2:1987;333-345.
16. Dawson G. J., Chau K. H., Cabal C. M., Yarbough P. O., Reyes G. R., Mushahwar I. K. Solid-phase enzyme-linked immunosorbent assay for hepatitis E virus IgG and IgM antibodies utilizing recombinant antigens and synthetic peptides. J. Virol. Methods. 38:1992;175-186.
17. Donati, M. C. Fagan, E. A. Harrison, T. J. 1997, Sequence analysis of full length HEV clones derived directly from human liver in fulminant hepatitis E, In, Viral Hepatitis and Liver Disease, M. RizzettoR. H. PurcellJ. L. GerinG. Verme, 313, 316, Edizioni Minerva Medica, Turin, Italy.
18. Drabick J. J., Gambel J. M., Gouvea V. S., Caudill J. D., Sun W., Hoke C. H. Jr., Innis B. L. A cluster of acute hepatitis E infection in United Nations Bangladeshi peacekeepers in Haiti. Am. J. Trop. Med. Hyg. 57:1997;449-454.
19. Favorov M. O., Khudyakov Y. E., Fields H. A., Khudyakova N. S., Padhye N., Alter M. J., Mast E., Polish L., Yashina T. L., Yarasheva D. M., Onischenko G. G., Margolis H. S. Enzyme immunoassay for the detection of antibody to hepatitis E virus based on synthetic peptides. J. Virol. Methods. 46:1994;237-250.
20. Favorov M. O., Khudyakov Y. E., Mast E. E., Yashina T. L., Shapiro C. N., Khudyakova N. S., Jue D. L., Onischenko G. G., Margolis H. S., Fields H. A. IgM and IgG antibodies to hepatitis E virus (HEV) detected by an enzyme immunoassay based on an HEV-specific artificial recombinant mosaic protein. J. Med. Virol. 50:1996;50-58.
21. Fields H. A., Favorov M. O., Margolis H. S. The hepatitis E virus A review. J. Clin. Immunoassay. 16:1993;215-223.
22. Fields H. A., Khudyakov Y. E., Favorov M. O., Khudyakova N. S., Cong M.-E., Holloway B. F., Lambert S. B., Jue D. L. Artificial mosaic proteins as new immunodiagnostic reagents: The hepatitis E virus experience. Clin. Diagn. Virol. 5:1996;167-179.
23. Goldsmith R., Yarbough P. O., Reyes G. R., Fry K. E., Gabor K. A., Kamel M., Zakaria S., Amer S., Gaffar Y. Enzyme-linked immunosorbent assay for diagnosis of acute sporadic hepatitis E in Egyptian children. Lancet. 339:1992;328-331.
24. Gouvea V., Snellings N., Cohen S. J., Warren R. L., Myint K. S. A., Shrestha M. P., Vaughn D. W., Hoke C. H. Jr., Innis B. L. Hepatitis E virus in Nepal: Similarities with the Burmese and Indian variants. Virus Res. 52:1997;87-96.
25. He J., Tam A. W., Yarbough P. O., Reyes G. R., Carl M. Expression and diagnositic utility of hepatitis E virus putative structural proteins expressed in insect cells. J. Clin. Microbiol. 31:1993;2167-2173.
26. Huang C.-C., Nguyen D., Fernandez J., Yun K. Y., Fry K. E., Bradley D. W., Tam A. W., Reyes G. R. Molecular cloning and sequencing of the Mexico isolate of hepatitis E virus (HEV). Virology. 191:1992;550-558.
27. Huang R., Nakazono N., Ishii K., Kawamata O., Kawaguchi R., Tsukada Y. Existing variations on the gene structure of hepatitis E virus strains from some regions of China. J. Med. Virol. 47:1995;303-308.
28. Khudyakov Y. E., Favorov M. O., Khudyakova N. S., Cong M.-E., Holloway B. P., Padhye N., Lambert S. B., Jue D. L., Fields H. A. Artificial mosaic protein containing antigenic epitopes of hepatitis E virus. J. Virol. 68:1994b;7067-7074.
29. Khudyakov Y. E., Khudyakova N. S., Fields H. A., Jue D., Starling C., Favorov M. O., Krawczynski K., Polish L., Mast E., Margolis H. Epitope mapping in proteins of hepatitis E virus. Virology. 194:1993;89-96.
30. Khudyakov Y. E., Khudyakova N. S., Jue D. L., Wells T. W., Padhya N., Fields H. A. Comparative characterization of antigenic epitopes in the immunodominant region of the protein encoded by open reading frame 3 in Burmese and Mexican strains of hepatitis E virus. J. Gen. Virol. 75:1994a;641-646.
31. Krawczynski, K. Bradley, D. Ajdukiewicz, A. Alter, M. Caredda, F. Dilawari, J. Hlady, G. Innis, B. Kane, M. Nasidi, A. Redeker, A. Stetler, H. Toukan, A. Yoffee, B. 1991, Virus-associated antigen and antibody of epidemic non-A, non-B hepatitis: serology of outbreaks and sporadic cases, In, Viral Hepatitis C, D, and E, T. ShikataR. H. PurcellT. Uchida, 229, 236, Elsevier, Amsterdan.
32. Li F., Torresi J., Locarnini S. A., Zhuang H., Zhu W., Guo X., Anderson D. A. Amino-terminal epitopes are exposed when full-length open reading frame 2 of hepatitis E virus is expressed inEscherichia coli, J. Med. Virol. 52:1997;289-300.
33. Li F., Zhuang H., Kolivas S., Locarnini S., Anderson D. Persistent and transient antibody responses to hepatitis E virus detected by Western immunoblot using open reading frame 2 and 3 and glutathione S-transferase fusion proteins. J. Clin. Microbiol. 32:1994;2060-2066.
34. Lok A. S. F., Kwan W.-K., Moeckli R., Yarbough P. O., Chan R. T., Reyes G. R., Lai C.-L., Chung H.-T., Lai T. S. T. Seroepidemiological survey of hepatits E in Hong Kong by recombinant-based enzyme immunoassays. Lancet. 340:1992;1205-1208.
35. Mcatee C. P., Zhang Y. F., Yarbough P. O., Brid T., Fuerst T. R. Purification of a soluble hepatitis E open reading frame 2-derived protein with unique antigenic properties. Prot. Expr. Purif. 8:1996;262-270.
36. Meng J., Dubreuil P., Pillot J. A new PCR-based seroneutralization assay in cell culture for diagnosis of hepatitis E. J. Clin. Microbiol. 35:1997a;1373-1377.
37. Meng, J. Guinet, R. Pillot, J. 1996, Infection of PLC/PRF/5 cells with the hepatitis E virus, In, Enterically-Transmitted Hepatitis Viruses, Y. BuissonP. CoursagetM. Kane, 336, 345.
38. Meng X.-J., Purcell R. H., Halbur P. G., Lehman J. R., Webb D. M., Tsareva T. S., Haynes J. S., Thacker B. J., Emerson S. U. A novel virus in swine is closely related to the human hepatitis E virus. Proc. Natl. Acad. Sci. USA. 94:1997b;9860-9865.
39. Panda S. K., Nanda S. K., Zafrullah M., Ansari I. H., Ozdener M. H., Jameel S. An Indian strain of hepatitis E virus (HEV): Cloning, sequence, and expression of structural region and antibody responses in sera from individuals from an area of high-level HEV endemicity. J. Clin. Microbiol. 33:1995;2653-2659.
40. Pillot J., Sharma M. D., Lazizi Y., Budkowska A., Dauguet C., Galimand M., Sarthou J. L. Immunological characterization of a viral agent involved in epidemic and sporadic non A non B hepatitis. Ann. Inst. Pasteur/Virol. 138:1987;145-158.
41. Pillot J., Turkoglu S., Dubreuil P., Cosson A., Lemaigre G., Meng J., Lazizi Y. Cross-reactive immunity against different strains of the hepatitis E virus transferable by simian and human sera. Coll. R. Acad. Sci. Paris. 318:1995;1059-1064.
42. Purcell, R. H. 1996, Hepatitis E virus, In, Fields Virology, B. N. FieldsD. M. KnipeP. M. HowleyR. M. ChanockJ. L. MelnickT. P. MonathB. RoizmanS. E. Straus, 2831, 2843, Lippincott-Raven Publishers, Philadelphia.
43. Purcell, R. H. Ticehurst, J. R. 1988, Enterically transmitted non-A, non-B hepatitis: Epidemiology and clinical characteristics, Viral Hepatitis and Liver Disease, A. J. Zuckerman, 131, 137, A. R. Liss, New York.
44. Purdy M. A., McCaustland K. A., Krawczynski K., Spelbring J., Reyes G. R., Bradley D. W. Preliminary evidence that a trpE-HEV fusion protein protects cynomolgus macaques against challenge with wild-type hepatitis E virus (HEV). J. Med. Virol. 41:1993;90-94.
45. Purdy M. A., McCaustland K. A., Krawczynski K., Tam A., Beach M. J., Tassopoulos N. C., Reyes G. R., Bradley D. W. Expression of a hepatitis E virus (HEV)-trpE fusion protein containing epitopes recognized by antibodies in sera from human cases and experimentally infected primates. Arch Virol. 123:1992;335-349.
46. Reyes G. R., Purdy M. A., Kim J. P., Luk K. C., Young L. M., Fry K. E., Bradley D. W. Isolation of a cDNA from the virus responsible for enterically transmitted non-A, non-B hepatitis. Science. 247:1990;1335-1339.
47. Schlauder G. G., Dawson G. J., Erker J. C., Kwo P. Y., Knigge M. F., Smalley D. L., Rosenblatt J. E., Desai S. M., Mushahwar I. K. The sequence and phylogenetic analysis of a novel hepatitis E virus isolated from a patient with acute hepatitis reported in the United States. J. Gen. Virol. 79:1998;447-456.
48. Shimizu Y. K., Hijikata M., Iwamoto A., Alter H. J., Purcell R. H., Yoshikura H. Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses. J. Virol. 68:1994;1494-1500.
49. Shimizu Y. K., Igarashi H., Kiyohara T., Cabezon S., Farci P., Purcell R. H., Yoshikura H. A hyperimmune serum against a synthetic peptide corresponding to the hypervariable region 1 of hepatitis C virus can prevent viral infection in cell cultures. Virology. 223:1996;409-412.
50. Tam A. W., Smith M. M., Guerra M. E., Huang C.-C., Bradley D. W., Fry K. E., Reyes G. R. Hepatitis E virus (HEV): Molecular cloning and sequencing of the full-length viral genome. Virology. 185:1991;120-131.
51. Tsarev S. A., Emerson S. U., Reyes G. R., Tsareva T. S., Legters L. J., Malik I. A., Iqbal M., Purcell R. H. Characterization of a prototype strain of hepatitis E virus. Proc. Natl. Acad. Sci. USA. 89:1992;559-563.
52. Tsarev S. A., Tsareva T. S., Emerson S. U., Govindarajan S., Shapiro M., Gerin J. L., Purcell R. H. Successful passive and active immunization of cynomolgus monkeys against hepatitis E. Proc. Natl. Acad. Sci. USA. 91:1994;10198-10202.
53. Tsarev S. A., Tsareva T. S., Emerson S. U., Kapikian A. Z., Ticehurst J., London W., Purcell R. H. ELISA for abtibody to hepatitis E virus (HEV) based on complete open-reading frame-2 protein expressed in insect cells: Identification of HEV infection in primates. J. Infect. Dis. 168:1993;369-378.
54. van Cuyck-Gandré H., Zhang H. Y., Tsarev S. A., Clements N. J., Cohen S. J., Caudill J. D., Buisson Y., Coursaget P., Warren R. L., Longer C. F. Characterization of hepatitis E virus (HEV) from Algeria and Chad by partial genome sequence. J. Med. Virol. 53:1997;340-347.
55. Yarbough P. O., Tam A. W., Fry K. E., Krawczynski K., McCaustland K. A., Bradley D. W., Reyes G. R. Hepatitis E virus: Identification of type-common epitopes. J. Virol. 65:1991;5790-5797.
56. Yin S., Purcell R. H., Emerson S. U. A new Chinese isolate of hepatitis E virus: Comparison with strains recovered from different geographical regions. Virus Genes. 9:1994;23-32.
57. Yin S., Tsarev S. A., Purcell R. H., Emerson S. U. Partial sequence comparison of eight new Chinese strains of hepatitis E virus suggests the genome sequence is relatively stable. J. Med. Virol. 41:1993;230-241.
58. Zibert A., Dudziak P., Schreier E., Roggendorf M. Characterization of antibody response to hepatitis C virus protein E2 and significance of hypervariable region 1-specific antibodies in viral neutralization. Arch. Virol. 142:1997;523-534.